Gerald Lee, MD; Stanley Fineman, MD; Shyam Joshi, MD; Disclosures

Recorded 7/23/2025
AllergyWatch May/June 2025 issue

To download the mp3 file, right click on the player and select Save audio as.

Interested in claiming CME for this episode? Click here

Show Notes

Welcome to another episode of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology. For today’s episode we will be reviewing articles from Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.

Today we joined by Dr. Shyam Joshi, MD, Associate Professor and Section Chief at Oregon Health & Science University and Associate Editor of Allergy Watch. We will be reviewing the May-June 2025 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.

To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!

Articles Reviewed:

  1. Outcomes of intravenous immunoglobulin treatment of immunocompromised patients with viral respiratory infections
  2. A 1-Year Weight Management Program for Difficult-to-Treat Asthma With Obesity: A Randomized Controlled Study
  3. Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome criteria

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Speaker Disclosures back to top

Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose

Stanley Fineman, MD
No relevant financial relationships with ineligible companies to disclose

Shyam Joshi, MD
Advisor: Novartis
Speaker: Novartis
Consultant: Merida Bioscience